Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease

Background. Midkine (MK), a new heparin-binding growth factor, plays important roles in a variety of biological phenomena such as carcinogenesis, inflammation, and angiogenesis. In this study, we aimed to evaluate serum midkine (SMK) and nodular midkine (NMK) levels in patients with thyroid nodules...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Endocrinol
Päätekijät: Kuzu, Fatih, Arpaci, Dilek, Unal, Mustafa, Altas, Ayfer, Haytaoglu, Gürkan, Can, Murat, Barut, Figen, Kokturk, Furuzan, Ilikhan, Sevil Uygun, Bayraktaroglu, Taner
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4944023/
https://ncbi.nlm.nih.gov/pubmed/27446208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6035024
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia